Name | PF-06439015 |
---|
Description | PF-06439015 is a potent and selective inihibitor that overcomes clinical ALK (receptor tyrosine kinase anaplastic lymphoma kinase) mutations resistant to Crizotinib. |
---|
Molecular Formula | C23H25FN6O5S2 |
---|---|
Molecular Weight | 548.6084 |